Shanghai Runda Medical plans board elections, related party transactions for 2026

Shanghai Runda Medical Technology announced a board meeting on December 16, 2025, to approve the nomination of candidates for its sixth board of directors, including six non-independent and four independent directors. The board also approved a new remuneration management system for directors and senior management, which will be submitted to the shareholders' meeting for approval.

Additionally, the board discussed and approved the forecast for 2026 related party transactions, totaling 80,070.00 yuan, which includes purchases of goods, sales of goods, and labor services with various associated companies. These transactions, deemed necessary for the company’s normal operations, will also require shareholder approval.

To address these key proposals, the company will convene its first extraordinary general meeting for 2026 on January 6, 2026, in Shanghai. The resolutions approved at the board meeting will proceed to the shareholders for final deliberation and approval.